Applied Therapeutics Inc (APLT)
8.69
-0.32
(-3.55%)
USD |
NASDAQ |
Nov 15, 16:00
8.79
+0.10
(+1.15%)
After-Hours: 20:00
Applied Therapeutics Debt to Equity Ratio: 0.00 for Sept. 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2024 | 0.00 |
| June 30, 2024 | 0.00 |
| March 31, 2024 | 0.00 |
| December 31, 2023 | -0.0181 |
| Date | Value |
|---|---|
| September 30, 2023 | -0.0702 |
| June 30, 2023 | -0.2861 |
| March 31, 2023 | -0.1311 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-0.2861
Minimum
Jun 2023
--
Maximum
Mar 2024
-0.0722
Average
-0.0181
Median
Dec 2023
Debt to Equity Ratio Benchmarks
| ResMed Inc | 0.1304 |
| Axonics Inc | 0.00 |
| Organon & Co | 17.75 |
| NovaBay Pharmaceuticals Inc | 0.0476 |
| Palatin Technologies Inc | 0.00 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 106.57M |
| Total Liabilities (Quarterly) | 100.67M |
| Shareholders Equity (Quarterly) | 5.892M |
| Current Ratio | 1.057 |
| Net Debt Paydown Yield | 0.03% |